ASCENDIA PHARMACEUTICALS, INC. — SEC Form D Filing
ASCENDIA PHARMACEUTICALS, INC. filed an SEC Form D on July 24, 2026, reporting $4.08M raised in Other Health Care.
Form D filing details
- Filing
- SEC Form D
- Filing date
- July 24, 2026
- Amount reported
- $4.08M
- Round stage
- Seed
- Industry
- Other Health Care
- Website
- https://ascendiapharma.com
What the company does
Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE
Problem
Pharmaceutical companies struggle to efficiently develop and scale new drug formulations due to complex scientific challenges and regulatory hurdles.
Solution
ASCENDIA PHARMACEUTICALS, INC. provides specialized contract development and manufacturing services for complex pharmaceutical formulations, helping clients bring new drugs to market faster and more reliably.
Why now
The specific timing catalyst for ASCENDIA PHARMACEUTICALS is unclear from available information.
Source: SEC EDGAR Form D filing